Sharps Compliance (NASDAQ:SMED) Upgraded at TheStreet

TheStreet upgraded shares of Sharps Compliance (NASDAQ:SMED) from a d+ rating to a c- rating in a research note released on Wednesday morning, TheStreetRatingsTable reports.

Several other analysts have also weighed in on the stock. Robert W. Baird began coverage on shares of Sharps Compliance in a research note on Wednesday, July 24th. They set a buy rating and a $4.50 target price for the company. Zacks Investment Research lowered shares of Sharps Compliance from a hold rating to a strong sell rating in a research note on Saturday, May 25th. Roth Capital began coverage on shares of Sharps Compliance in a research note on Wednesday, July 24th. They set a buy rating and a $4.50 target price for the company. Finally, Barrington Research reiterated a buy rating and set a $4.50 target price on shares of Sharps Compliance in a research note on Tuesday, May 21st. One equities research analyst has rated the stock with a sell rating and three have assigned a buy rating to the stock. Sharps Compliance currently has an average rating of Buy and an average price target of $4.38.

Shares of NASDAQ:SMED opened at $3.90 on Wednesday. The company has a current ratio of 2.49, a quick ratio of 1.95 and a debt-to-equity ratio of 0.04. The company has a fifty day simple moving average of $3.67 and a 200 day simple moving average of $3.58. The firm has a market cap of $66.02 million, a PE ratio of 390.00, a price-to-earnings-growth ratio of 1.45 and a beta of 0.24. Sharps Compliance has a 12-month low of $2.97 and a 12-month high of $4.47.

Sharps Compliance (NASDAQ:SMED) last issued its quarterly earnings results on Wednesday, August 21st. The industrial products company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02. The business had revenue of $12.17 million during the quarter, compared to analyst estimates of $10.77 million. Sharps Compliance had a net margin of 0.48% and a return on equity of 0.83%. As a group, equities research analysts forecast that Sharps Compliance will post 0.06 EPS for the current fiscal year.

In other Sharps Compliance news, Director Parris H. Holmes, Jr. bought 40,000 shares of the stock in a transaction on Thursday, June 13th. The stock was purchased at an average price of $3.31 per share, for a total transaction of $132,400.00. Following the completion of the purchase, the director now directly owns 942,027 shares in the company, valued at $3,118,109.37. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last quarter, insiders have acquired 46,250 shares of company stock valued at $153,075. 20.70% of the stock is owned by insiders.

A number of hedge funds have recently added to or reduced their stakes in the business. Quantum Capital Management increased its stake in Sharps Compliance by 0.6% during the first quarter. Quantum Capital Management now owns 522,569 shares of the industrial products company’s stock valued at $1,913,000 after purchasing an additional 3,223 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of Sharps Compliance by 3.8% during the second quarter. BlackRock Inc. now owns 108,739 shares of the industrial products company’s stock valued at $387,000 after acquiring an additional 4,013 shares during the period. Lapides Asset Management LLC boosted its holdings in shares of Sharps Compliance by 13.3% during the second quarter. Lapides Asset Management LLC now owns 164,700 shares of the industrial products company’s stock valued at $586,000 after acquiring an additional 19,300 shares during the period. Wells Fargo & Company MN boosted its holdings in shares of Sharps Compliance by 8.3% during the second quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock valued at $1,512,000 after acquiring an additional 32,600 shares during the period. Finally, Morgan Stanley boosted its holdings in shares of Sharps Compliance by 34.3% during the second quarter. Morgan Stanley now owns 188,699 shares of the industrial products company’s stock valued at $672,000 after acquiring an additional 48,199 shares during the period. Hedge funds and other institutional investors own 20.19% of the company’s stock.

Sharps Compliance Company Profile

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.

Further Reading: Cost of Capital Explained

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.